+

DiaSorin

DiaSorin S.p.A. works in the field of biotechnology, within which it develops, produces and sells tests (reagents and analyzers for blood analysis) for the diagnosis of alterations in the patients health status of infectious, hormonal or tumor origin. At the beginning of 2020, with the spread of the new Coronavirus outbreak, DiaSorin promptly developed a molecular diagnostic test to detect all known variants of COVID-19 as well as having developed serological tests to detect the presence of specific antibodies.

Main objectives

The increased complexity of the supply chain both from the point of view of the distribution network and from the point of view of the managed product portfolio has prompted the company organization to quickly pursue the needs of the business, however, encountering some critical issues. In fact, the planning system was not fully aligned between its various components (commercial branches and production sites), causing on the one hand disruptions to final customers and on the other side causing obsolescence both at branch level and at production site level; a planning process that was also cumbersome because it was not supported by a structured system.

The company therefore wanted to invest in a Sales & Operation Planning system that would allow greater monitoring of the demand signal and greater coordination between the commercial branches and production sites.

Implemented solution

The modules identified as the building blocks of the solution refer to the following components of the sedApta suite:

 

TO RECEIVE THE DOCUMENT, PLEASE SUBMIT YOUR REQUEST:

    I read the report and authorize the usage of my personal data. More Info
    With reference to the new European Union Regulation RE 679/16 concerning data protection, we inform you that your data are collected by the company sedApta S.r.l. and will be used for the sole purpose of registering for our course/event or for processing your information request or for future communications through our newsletter. The communication of the requested data is to be understood as a manifestation of the consent to their treatment; failure to consent will make it impossible for you to process your request for information or to register for the course. The data controller is the sedApta S.r.l. Via Dino Col 4n, 16149 Genoa, Italy (accessible at the email address info@sedapta.com.) Data will only be processed by sedApta representatives and will not be disclosed outside the SedApta company or transferred to third countries outside the European Community You may at any time request sedApta Srl access to your personal data, with reference to Articles 15, 16, 17, 18, 20 or request access, correction, deletion and also limit or oppose the indicated treatments, by writing to the e-mail address communicated.If the treatment of the data by sedApta does not conform to the indicated purposes or to the law in force (RE 679/16), it can always contact the supervisory authority, indicating the specific case. We also inform you that by consulting the pages of our website, the company does not implement any type of user profiling or other authorized decision-making processes.
    Close

    Register to get additional information on our customers’ specific deliverables and understand how sedApta can be perceived as a key player for digital transformation and production process management.

    Do you want more information?

    Contact